FDA
-
-
-
-
-
-
-
Bright Minds Biosciences (DRUG) Reports Positive qEEG Data from its First-in-Human Phase 1 Study of BMB-101
-
-
-
-
-
-
-
Dragon Pharmaceutical, Inc. (DRUG) Successfully Completes 28-Day Toxicology Studies and Advancement to First-in-Human Clinical Trial
-
-
-
-
-
322,184 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

